Determinants of Disability in Multiple Sclerosis at Various Disease Stages
Authors:
- Marco RovarisMRMarco Rovaris
- Elda JudicaEJElda Judica
- Maria Pia SormaniMSMaria Pia Sormani
- Vittorio MartinelliVMVittorio Martinelli
- Giancarlo ComiGCGiancarlo Comi
- Massimo FilippiMassimo Filippi
Open Access
- 1 August 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (8) , 1163-1168
Abstract
Although conventional magnetic resonance imaging (cMRI) is characterized by a high sensitivity for detecting the presence of multiple sclerosis (MS) lesions, the magnitude of the correlation between the severity of disability and the extent of cMRI abnormalities is, at best, modest.1 There are several reasons why cMRI findings cannot fully explain the clinical variability of MS. These include the inability of cMRI to disclose and quantify the heterogeneous pathological features of MS.1 In addition, cMRI-derived metrics do not account for the presence of MS-related damage of the normal-appearing brain tissues, which is known to be more severe in the more disabling forms of the disease.2 A third explanation for the clinical and cMRI discrepancy is the different functional relevance of damage to central nervous system regions; for this reason, a strategy of “critical sampling” in studying MS may enable us to better quantify in vivo the severity of pathological features related to clinical impairment.3Keywords
This publication has 33 references indexed in Scilit:
- Diffusion MRI in multiple sclerosisNeurology, 2005
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic reviewBrain, 2005
- “Importance sampling”: A strategy to overcome the clinical/MRI paradox in MS?Journal of the Neurological Sciences, 2005
- Neuronal cell injury precedes brain atrophy in multiple sclerosisNeurology, 2004
- Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosisJournal of Neurology, 2003
- The clinico-radiological paradox in multiple sclerosis revisitedCurrent Opinion in Neurology, 2002
- Correlates of MS disability assessed in vivo using aggregates of MR quantitiesNeurology, 2001
- Linomide in relapsing and secondary progressive MSNeurology, 2000
- Total brain N‐acetylaspartate concentration in normal, age‐grouped females: Quantitation with non‐echo proton NMR spectroscopyMagnetic Resonance in Medicine, 1998